Cutting-edge tools shaping early-stage drug discovery
The Drug Discovery World Podcast
Release Date: 05/15/2025
The Drug Discovery World Podcast
The latest episode of the DDW podcast is available to listen to below. This week, Bruno Quinney speaks to DDW Editor Reece Armstrong and Senior Digital Content Editor Diana Turner to look ahead to the world of drug discovery, pharma and biotech in 2026. They explore why AI will continue to dominate in 2026, why obesity and breast cancer will attract investor attention, and how drug discovery will look to resolve the challenges of clinical trials. You can listen below, or find The Drug Discovery World Podcast on , and
info_outlineThe Drug Discovery World Podcast
The latest episode of the is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week's discoveries into Parkinson’s disease, allergies and common cancers could shape drug development. Elsewhere, why is the UK leading Europe’s biotech market? You can listen below, or find The Drug Discovery World Podcast on , and
info_outlineThe Drug Discovery World Podcast
The latest episode of the is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, an innovative therapy showed encouraging results in tackling melanoma. Elsewhere, why is a former American football player getting involved with a biopharmaceutical company? You can listen below, or find The Drug Discovery World Podcast on , and
info_outlineThe Drug Discovery World Podcast
The latest episode of the is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, new research in women’s health uncovered significant findings related to endometriosis and ovarian cancer. Elsewhere, can ageing be reversed? You can listen below, or find The Drug Discovery World Podcast on , and
info_outlineThe Drug Discovery World Podcast
This is the latest episode of the free DDW Narrated Podcast. The episode covers two articles written for DDW Volume 25, Issue 2, Spring 2024. The first article is called . Ben Holland, CTO and Co-Founder of Antiverse, discusses how artificial intelligence and machine learning are benefitting antibody discovery and design. The second article is called . In the piece, DDW Editor Reece Armstrong speaks to Sean McClain, Founder & CEO of Absci, about the rise of generative AI in life sciences. You can listen below, or find The Drug Discovery World Podcast on , and
info_outlineThe Drug Discovery World Podcast
The latest episode of the is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, a new report found breast cancer was the world’s most studied disease for the fifth year running. That same report predicted obesity to break into the top five, with weight loss a key theme across other headlines last week. You can listen below, or find The Drug Discovery World Podcast on , and
info_outlineThe Drug Discovery World Podcast
The latest episode of the is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, a research team found that a hidden molecular switch fuels obesity. Elsewhere, AI-generated antibodies have been tolerated by human immune cells. You can listen below, or find The Drug Discovery World Podcast on , and
info_outlineThe Drug Discovery World Podcast
The latest episode of the is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, innovative treatments showed potential to treat neurodegenerative diseases, allergies and arthritis. Elsewhere, a study showed China is becoming the dominant force in the biotech sector. You can listen below, or find The Drug Discovery World Podcast on , and
info_outlineThe Drug Discovery World Podcast
The latest episode of the is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, a trade agreement between the UK and the US promised to support the life sciences industry and secure access to drugs. Elsewhere, novel therapies could break new ground in treating neurodegenerative diseases. You can listen below, or find The Drug Discovery World Podcast on , and
info_outlineThe Drug Discovery World Podcast
The latest episode of the is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, gene therapies provided solutions for complex conditions, most notably in Hunter syndrome but also in amyotrophic lateral sclerosis (ALS). Elsewhere, research showed antibody-drug conjugate precision therapy could prevent breast cancer. You can listen below, or find The Drug Discovery World Podcast on , and
info_outlineThis is the latest episode of the free DDW narrated podcast, titled “Cutting-edge tools shaping early-stage drug discovery”, which covers three articles written for DDW Volume 24 – Issue 4, Fall 2023. They are called: “The use-case for NGS”, “Are organ-chips the future of preclinical research?” and “What spatial biology can tell us about disease and drug discovery”.
In the first article, DDW Editor Reece Armstrong speaks to Dr Darrell Green, Lecturer in RNA Biology, Biomedical Research Centre, Norwich Medical School University of East Anglia, about his work using next generation sequencing (NGS) and the areas the technology is impacting within drug discovery and development.
In the second article, Diana Spencer catches up with Lorna Ewart, PhD, Chief Scientific Officer of Emulate, about the rise of organ-on-a-chip technology.
In the third article, DDW Editor Reece Armstrong speaks to Benedikt Nilges, Head of Technology and Data Analytics at OMAPiX about spatial biology’s use in drug discovery and bettering our understanding of disease.